Comparison of chocolate to cacao-free white chocolate in Parkinson's disease: A single-dose, investigator-blinded, placebo-controlled, crossover trial

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2447-2451

  Wolz, Martin ^a   Schleiffer, Christine ^a   Klingelhöfer, Lisa ^a   Schneider, Christine ^a   Proft, Florian ^b   Schwanebeck, Uta ^a   Reichmann, Heinz ^a   Riederer, Peter ^b   Storch, Alexander ^a,c  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Biogenic amines; Chocolate; Investigator blind randomized clinical trial; Parkinson's disease; Pharmacological effects

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BIOGENIC AMINE; CAFFEINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PHENETHYLAMINE; PLACEBO;

ADULT; ARTICLE; CACAO; CACAO FREE WHITE CHOCOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; FOOD INTAKE; HUMAN; MALE; NAUSEA; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE; VOMITING;

ADULT; AGED; CACAO; CANDY; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RESEARCH PERSONNEL; SINGLE-BLIND METHOD;

EID: 84868194050     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6527-1     Document Type: Article

References (19)

1. Ashihara H, Sano H, Crozier A (2008) Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry 69:841-856
2. di Tomaso E, Beltramo M, Piomelli D (1996) Brain cannabinoids in chocolate. Nature 382:677-678 (Pubitemid 26282162)
3. Fahn S, Elton RL, Committee UD (1987) The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, Florham Park, pp 153-163, 293-304
4. Hautzinger M, Bailer M, Worall H, Keller F (1994) Beck-Depressions- inventar (BDI). Huber Publisher, Bern
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
6. Hughes AJ, Lees AJ, Stern GM (1990) Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet 336:32-34 (Pubitemid 20207878)
7. Jankovic J (2008) Are adenosine antagonists, such as istradefyl-line, caffeine, and chocolate, useful in the treatment of Parkinson's disease? Ann Neurol 63:267-269 (Pubitemid 351499855)
8. Jones B, Kenward MG (2008) Design and analysis of cross-over trials. Chapman & Hall/CRC, Danvers
9. Parker G, Parker I, Brotchie H (2006) Mood state effects of chocolate. J Affect Disord 92:149-159
10. Pastore P, Favaro G, Badocco D, Tapparo A, Cavalli S, Saccani G (2005) Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr 1098:111-115 (Pubitemid 41682415)
11. Qureshi GA, Qureshi AR, Bergstrom J (1989) Quantitation of free amino acids in plasma and muscle samples in healthy subjects and uremic patients by high-performance liquid chroma-tography and fluorescence detection. J Pharm Biomed Anal 7:377-384
12. Riederer PF, Burger R (2009) Ist Schokolade ein Psychophar-makon? Die Rolle von β-Phenylethylamin als Psychostimulus. Psychopharmakotherapie 16:26-31
13. Rusconi M, Conti A (2010) Theobroma cacao L., the food of the gods: a scientific approach beyond myths and claims. Pharmacol Res 61:5-13
14. Schrag A, Sampaio C, Counsell N, Poewe W (2006) Minimal clinically important change on the unified Parkinson's disease rating scale. Mov Disord 21:1200-1207 (Pubitemid 44336608)
15. Shulgin A, Shulgin A (2010) #142 PEA Phenylethylamine. In: PIHKAL Erowid Online Books
16. Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Muller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H (2007) Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol 64:938-944 (Pubitemid 47047992)
17. Tarka SM Jr (1982) The toxicology of cocoa and methylxan-thines: a review of the literature. Crit Rev Toxicol 9:275-312
18. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649-2653
19. Wolz M, Kaminsky A, Lohle M, Koch R, Storch A, Reichmann H (2009) Chocolate consumption is increased in Parkinson's disease. Results from a self-questionnaire study. J Neurol 256:488-492